Skip to content

Biohaven

US · BHVN #2805 by market cap Listed 2017
12.39 -1.26 -9.23%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

About Biohaven

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Founded
2022
CEO
Dr. Vlad Coric, M.D.
Employees
274
Headquarters
New Haven, Connecticut, United States of America
Fiscal year end
12-31
Website
biohaven.com

Company profile

Exchange
US
Symbol
BHVN
Market-cap rank
#2805
Listing date
2017-05-04
Market cap
1.87B
Float cap
1.44B
Shares out
151.06M
Float shares
116.57M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:01:17 · For reference only, not investment advice and not tailored to your situation.

Biohaven discussion 0 comments

Add a comment